Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
9,915,066
-
Shares change
-
+915,998
-
Total reported value, excl. options
-
$175,891,040
-
Value change
-
+$12,159,109
-
Number of buys
-
40
-
Number of sells
-
-10
-
Price
-
$17.74
Significant Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q1 2019
55 filings reported holding KZR - Kezar Life Sciences Inc - COMMON-STOCK as of Q1 2019.
Kezar Life Sciences Inc - COMMON-STOCK (KZR) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9,915,066 shares
.
Largest 10 shareholders include FMR LLC (2,756,333 shares), Cormorant Asset Management, LP (1,300,000 shares), BB BIOTECH AG (1,220,503 shares), EcoR1 Capital, LLC (856,471 shares), BlackRock Inc. (635,575 shares), COWEN INC. (492,006 shares), VANGUARD GROUP INC (405,983 shares), FRAZIER MANAGEMENT LLC (370,081 shares), FRANKLIN RESOURCES INC (334,500 shares), and VICTORY CAPITAL MANAGEMENT INC (224,343 shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.